PHARMACEUTICAL COMPOSITION, CONTAINING CILOSTAZOL AS ACTIVE INGREDIENT, FOR PREVENTING HEART FAILURE OR DILATED CARDIOMYOPATHY CAUSED BY DOXORUBICIN

摘要

The present invention relates to a pharmaceutical composition for preventing heart failure or dilated cardiomyopathy specifically induced by doxorubicin, the composition containing cilostazol as an active ingredient. The pharmaceutical composition of the present invention, while keeping the effects of an anticancer drug, doxorubicin, can improve the stability of the doxorubicin by containing, as an active ingredient, cilostazol, which is an adjurvant reducing side effects resulting from the treatment with only the doxorubicin, thereby improving an anticancer therapeutic effect.